The Orlando Medical Corporation financial statements follow. 15 (Click the icon to view the consolidated balance sheets.) B (Clic Orlando Medical's quick (acid-test) ratio at year-end 2018 is closest to O A. 0.68 O B. $8,578 million O C. 0.45. OD. 0.75. Data Table view Orlando Medical Corporation Consolidated Statements of Financial Position December 31, (In Millions) 2018 2017 Assets: Current assets Cash and cash equivalents 4,333 5 4,226 Short-term investments 845 520 Accounts and notes receivable 3,400 2,403 Inventories, at cost 433 411 1,638 1,226 Prepaid expense and other current assets Total current assets 10,649 8.786 Property and equipment, net 1,555 907 Investments 6,804 5.199 303 155 Other non-current assets 19,311 S 15.047 Total assets Liabilities and stockholder's equity: Print Print Done Done m=yes 7 of 10 (3 complete) Data Table 7,708 $ 3.676 11,384 304 1,701 6,009 3,033 9,042 305 1.179 13,389 10,526 Liabilities and stockholder's equity: Current liabilities Accounts payable Accrued and other liabilities Total current liabilities Long-term debt Other non-current liabilities Total liabilities Stockholders' equity Preferred stock and capital in excess of $0.02 par value; shares issued and outstanding: none Common stock and capital in excess of $0.05 par value; shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost; 183 and 123 shares, respectively Retained earnings Other comprehensive loss Other 7803 7,001 (4,401 4.676 1990 79 922 Print Done i Data Table view CUTTEI HUNGE 7,708 S 3,676 3,033 11,384 304 1,701 9,042 305 1,179 10,526 13,389 Accounts payable Accrued and other liabilities Total current liabilities Long-term debt Other non-current liabilities Total liabilities Stockholders' equity Preferred stock and capital in excess of $0.02 par value; shares issued and outstanding: none Common stock and capital in excess of $0.05 par value; shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost; 183 and 123 shares, respectively Retained earnings Other comprehensive loss Other Total stockholders' equity Total liabilities and stockholders' equity 7.803 (6.444) 4676 (79) (34) 5,922 19.311 5 7,001 (4.401) 1.990 (25 15.047 Done i Data Table Orlando Medical Corporation Consolidated Statements of Income Year ended December 31, (In Millions, Except per Share Amounts) 2018 2017 2016 Net revenue 42,666 $ 35,220 5 31,111 35,147 29,255 25,492 Cost of goods sold 7,519 5,965 5,619 Gross profit Operating expenses: Selling, general, and administrative 3,341 3,250 2,985 Research, development, and engineering 544 553 Special charges 3,885 3,803 Total operating expenses Operating income 3,634 2,162 1,586 153 196 (30 Investment and other income (loss), net 3.787 Income before income taxes 2.358 1.556 1,136 940 Income tax expense 2 651 1.418 $ 536 512 4,033 472 1,084 Print Done Data Table 2018 2017 42,666 $ 35,220 5 35,147 29,255 7,519 SE5,965 2016 31,111 25,492 5,619 (In Millions, Except per Share Amounts) Net revenue Cost of goods sold Gross profit Operating expenses: Selling, general, and administrative Research, development, and engineering Special charges Total operating expenses Operating income Investment and other income (loss), net Income before income taxes 3,341 544 3,250 553 2,985 536 512 4033 3.885 3,803 3,634 153 2.162 196 1,586 (30) 2,358 1.556 3,787 1,136 940 Income tax expense 2,651 S 1.418 S 1084 Net income 0.959 Earnings per common share: Basic Print Done